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Matrilin-2 is a member of von Willebrand factor A
containing extracellular matrix proteins in which the
cDNA-derived sequence shows similar domain organiza-
tion to cartilage matrix protein/matrilin-1, but informa-
tion on the protein structure is limited. Here we studied
the oligomerization potential of a synthetic peptide
NH2-ENLILFQNVANEEVRKLTQRLEEMTQRMEALE-
NRLKYR-COOH corresponding to the C-terminal se-
quence of mouse matrilin-2. The central portion of this
sequence shows a periodicity of hydrophobic residues
occupying positions a and d of a heptad pattern (abc-
defg)n, which is characteristic for a-helical coiled-coil
proteins. Circular dichroism spectroscopy revealed a
high a-helical content, and the shape of the spectra is
indicative for a coiled-coil conformation. Chemical
cross-linking and size exclusion chromatography sug-
gest a homotrimeric configuration. Thermal denatur-
ation in benign buffer shows a single cooperative tran-
sition with DH0 5 2375 kJ/mol. Melting temperatures Tm
varied from 38 to 51 °C within a concentration range of
10 to 85 mM, which is about 35 °C lower than determined
for a peptide corresponding to the C-terminal domain of
matrilin-1. The data suggest that despite the low se-
quence identity within this region, matrilin-2 will form a
homotrimer as matrilin-1 does.
Matrilins form a subfamily of extracellular matrix proteins
containing von Willebrand factor A-like domains. Its prototype
member, matrilin-1 (also known as cartilage matrix protein), is
specifically localized in some types of the hyaline cartilage (1)
where it can interact with aggrecan and collagen type II fibrils
(2–4), but it can also form a filamentous network by itself (5).
Its primary structure contains two N-terminal sequence seg-
ments with similarities to the von Willebrand factor A domain
separated by an epidermal growth factor-like domain and a
short unique C-terminal domain (6–9) that was recently found
to be responsible for the oligomerization into homotrimers by
assembling into a three-stranded a-helical coiled coil (4, 10, 11).
Meanwhile, cDNA-derived sequences of two different gene
products have been established that show a similar domain
structure and are consequently named matrilin-2 and matri-
lin-3 (12–14). Within the matrilin-2 sequence, the two von
Willebrand factor domains are separated by 10 epidermal
growth factor-like domains, whereas matrilin-3 lacks the sec-
ond von Willebrand factor domain and contains four epidermal
growth factor-like tandem repeats. In contrast to matrilin-1,
matrilin-2 is absent from epiphyseal and other cartilages, but
is found in high abundance in the limbs, calvaria, uterus, and
heart and in lower amounts in skeletal muscle, brain, and skin
(12). Expression studies suggest a similar tissue distribution
for matrilin-3 as found for matrilin-1. It mainly co-localizes
with collagen type II, especially in the periphery of cartilage in
sternum, femur, and trachea (13, 14).
Currently the oligomerization state of the new matrilins is
unknown. Preliminary data from SDS-polyacrylamide gel elec-
trophoresis run under nonreducing conditions revealed only
that matrilin-2 is not a monomeric protein (12). Although the
overall sequence similarity between the different matrilins
suggests a common evolutionary origin, it is lowest for the
C-terminal domain. Only 11 and 13 of the 38 C-terminal resi-
dues of matrilin-2 and -3, respectively, are identical with those
of matrilin-1 of the same species, and only two residues are
identical in all known matrilin sequences in corresponding
positions. To elucidate the oligomerization potential of matri-
lin-2, we synthesized a peptide corresponding to the 38 C-
terminal residues of mouse matrilin-2 and analyzed it by cir-
cular dichroism (CD)1 spectroscopy, chemical cross-linking,
and gel filtration chromatography. Our data indicate that this
sequence domain can assemble into a homotrimeric a-helical
coiled coil similar to matrilin-1 although with a lower thermal
stability.
EXPERIMENTAL PROCEDURES
Peptide Synthesis and Purification—Peptide synthesis was per-
formed by solid-phase chemistry on a Milligen/Biosearch model 9050
synthesizer using Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry.
The five arginine residues were protected by pentamethylchroman-
sulfonyl. Cleavage from the resin and deprotection were carried out
applying a two-step procedure as described (11). Purification was per-
formed by reversed phase HPLC using a YMC C18 column (20 3 250
mm) eluted with a linear binary gradient of acetonitrile/water from 25
to 50% containing 0.1% trifluoroacetic acid (7 ml/min) where the peptide
eluted at around 45% acetonitrile/water. The purified peptide gave a
single absorption peak at 220 nm when analyzed on an analytical C18
column. Peptide identity was confirmed by laser desorption mass spec-
trometry performed by the Protein and Carbohydrate Structure Facility
of the University of Michigan (Ann Arbor, MI). Concentrations were
determined spectrophotometrically assuming A1 cm
1% 5 3.32 at 276 nm as
calculated from the amino acid composition (15).
Circular Dichroism Spectroscopy and Thermodynamic Analysis—CD
spectra were recorded on an Aviv model 62DS spectrophotometer
equipped with a five-cell holder and a Hewlett-Packard Peltier temper-
ature controller. Spectra are normalized to mean residue ellipticities
([Q]MRW) with Mr 5 124 as derived from the sequence. Thermal tran-
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sition curves were recorded at 222 nm from 0 to 85 °C in 0.2 °C intervals
with a 0.2-min equilibration time. They were normalized to the fraction
of folded peptide F with F 5 (U 2 Uu (T))/(Un (T) 2 Uu(T)) where Un and
Uu represent ellipticities of the fully folded and unfolded species, re-
spectively, corrected for their temperature dependence by linear extrap-
olation of the low and high temperature baselines, and U is the observed
ellipticity.
Transition curves were interpreted assuming a two-state mechanism
in which three unfolded chains u combine to a native a-helical coiled-
coil trimer n (16). With the total peptide concentration c0 5 cu 1 3cn and
the degree of conversion to the coiled-coil F 5 3cn/c0, the equilibrium
constant K follows as K 5cn/cu
3 5 F/3c0
2 (1 2 F)3. With DG0 5 2RT ln
K 5 DH0 2 TDS0, it follows that at the transition midpoint (F 5 0.5 and
T 5 Tm) (Equation 1),
1
Tm
5
DS0 1 R ln~0.75c02!
DH0
(Eq. 1)
where DG0, DH0, DS0, R, and T are the standard free energy, enthalpy,
entropy, gas constant, and absolute temperature, respectively. Thus,
DH0 was calculated from the slope of 1/Tm versus ln (0.75 c0
2) for Tm
determined at different peptide concentrations. From single transition
curves, Tm and DH
0 were evaluated by a nonlinear least-squares Mar-
quardt-Levenberg fitting algorithm (Equation 2) of
lnK~T! 5
DH0
RT S TTm 2 1D2 ln~0.75 c02! (Eq. 2)
with DH0 and Tm as variables.
Crosslinking, Gel Electrophoresis, and Gel Filtration—Chemical
cross-linking was performed at different ionic strengths adjusted by
NaCl using bis(sulfosuccinimidyl)suberate BS3 and disuccinimidyl
glutarate (Pierce), which are homobifunctional N-hydroxysuccimide es-
ter analogs with a spacer arm length of 1.14 and 0.77 nm, respectively.
The peptide (cfinal 5 100 mM, in 20 mM KH2PO4/NaOH, pH 7.2, plus
NaCl) was incubated at various cross-linker concentrations for 1 h at
25 °C. The reaction was stopped by adding a 10-fold excess of Tris-HCl
contained in the sample buffer, and the aggregation state was analyzed
by Tris/Tricine SDS gel electrophoresis (17) using 16% acrylamide gels
containing 5 M urea and a 3% stacking gel. Gels were stained with
Coomassie Brilliant Blue G250 in 5% formaldehyde added to keep the
peptide in the gel (18).
Gel filtration was performed using a Superdex 75 prep grade column
(1 3 12 cm; Amersham Pharmacia Biotech) equilibrated in 0.25 M NaCl,
20 mM KH2PO4/NaOH, pH 7.2, at 4 °C. The column was eluted at 12
ml/h and calibrated using standard proteins of known viscosity radius,
and results were analyzed as described (11, 19).
RESULTS
Peptide Design and Coiled-coil Prediction—Although the
overall domain structure of matrilin-2 is similar to that of
matrilin-1, the low sequence similarity within its C-terminal
domain (Fig. 1) makes it uncertain whether the oligomerization
state is the same. The common 3-4-3-4 spacing of hydrophobic
residues allows to predict that in matrilin-2 this sequence
region will also form an a-helical coiled coil. When analyzed by
different algorithms, the probability for coiled-coil formation is
similarly high for both protein domains. The MultiCoil pro-
gram (20), aimed to differentiate between dimeric and trimeric
coiled coils, assigns the highest probabilities for a two-stranded
conformation.
To determine the secondary structure, stability, and oli-
gomerization state of matrilin-2, we synthesized a peptide,
designated MTR2-C38, corresponding to the 38 C-terminal res-
idues of the mouse sequence (Fig. 1). Within the mature pro-
tein, the first peptide residue is adjacent to Cys-Lys-Cys-918,
the cysteines of which might form interchain disulfide bridges
as it was shown for the corresponding residues of chicken
matrilin-1 (10, 23). The sequence differs from that of human
matrilin-2 by three structurally related residues (L923M,
V927L, K954R). All four coiled-coil predictions agree in their
assignment of heptad positions (abcdefg)nto each residue where
positions a and d are occupied by hydrophobic amino acids
except for Gln-25 (Fig. 1). Within an a-helical coiled coil, these
residues come into close contact as knobs filling holes in the
center and stabilize the oligomer by hydrophobic interactions
(for details, see e.g. Ref. 24). Further stabilization can arise
from intrahelical ionic interactions between oppositely charged
side chains of the type i3 i 1 3 and i3 i 1 4 (Fig. 1) (25). The
single putative interchain ionic pair Arg-945/Asp-950 might be
crucial for oligomerization specificity and chain orientation as
it was found for a corresponding peptide resembling the matri-
lin-1 C-terminal domain (26).
Secondary Structure of Peptide MTR2-C38—When analyzed
by far ultraviolet CD spectroscopy, MTR2-C38 shows a spec-
trum characteristic for a high a-helical content with extrema
around 192, 208, and 222 nm (Fig. 2), although the amplitudes
are slightly lower than observed for a corresponding peptide
resembling the matrilin-1 C-terminal domain (11). In 50% tri-
fluoroethanol, which disrupts the tertiary and quaternary
structure and stabilizes single a-helices (27), the amplitudes
increase, specifically at 208 nm. The relatively small increase
indicates that the peptide is almost fully a-helical in benign
buffer. As the n-p* transition (222 nm) is mainly indicative for
the a-helical content, whereas the p-p* transition (208 nm)
polarizes parallel to the helix axis, the ellipticity ratio [Q]222/
[Q]208 reflects whether the a-helix is monomeric or forms a
coiled coil (28, 29). For MTR2-C38, this ratio significantly de-
pends on the concentration and is greater than 0.98 at peptide
concentrations above 20 mM, which is compatible with the as-
sumption that MTR2-C38 forms an a-helical coiled coil (Fig. 2,
inset). The lower ratio of 0.87 observed at 5 mM might indicate
some dissociation that is also reflected in the lower ellipticities
FIG. 1. Coiled-coil probability of the C-terminal domain of
mouse matrilin-2. The sequence of the 38 C-terminal residues was
analyzed for its coiled-coil-forming potential using the programs Coils
(solid line) (21), version 2.2, applying the MTIDK matrix and using a 2.5
weight on residues in heptad positions a and d, PairCoil (dashed line)
(22), and MultiCoil (20), which differentiates between the possibilities
of forming a two-stranded (dotted line) or three-stranded (dashed-dot-
ted line) conformation. In each case, a window size of 28 residues was
used, and all algorithms agreed in the assignment of uninterrupted
heptad positions as indicated above the sequence corresponding to
peptide MTR2-C38. The first peptide residue corresponds to position
919 of the full-length sequence (12). Putative intrachain (spacing i 3 i
1 3; i 3 i 1 4, brackets) and interchain (heptad positions g-2d9, boxed,
thick bracket) ionic interactions are indicated. Hydrophobic residues in
heptad positions a and d are printed in reverse font. For comparison, the
36 and 38 C-terminal residues of mouse matrilin-1/cartilage matrix
protein (MTR1, Ref. 9) and matrilin-3 (MTR3, Ref. 14), respectively, are
included. Asterisks denote residues identical with MTR2, highlighting
the low sequence identity within this region.
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observed (data not shown).
Oligomerization State of Peptide MTR2-C38—The specific
homotrimeric association of matrilin-1 has been shown by elec-
tron microscopy of the reduced and unreduced native protein
(4), site-directed mutagenesis on recombinantly overexpressed
mini-gene matrilin-1 proteins (10), and analysis of peptides by
analytical ultracenrifugation, size exclusion chromatography,
and chemical cross-linking (11, 26). To test whether despite the
low sequence identity (Fig. 1), matrilin-2 can also assemble into
a homotrimer, we performed cross-linking studies on MTR2-
C38 using BS3 and disuccinimidyl glutarate, which differ in
their spacer arm length. Fig. 3A shows the reaction products
analyzed by SDS gel electrophoresis. At all cross-linker concen-
trations, major bands corresponding to a monomeric, dimeric,
and trimeric state appeared, but small amounts of higher oli-
gomerization states were detected at increased cross-linker
concentrations. The migration pattern is essentially uneffected
from the ionic strength in the 100–750 mM NaCl range (not
shown).
To test whether the different gel bands observed after cross-
linking reflect a heterogeneous population of oligomers in so-
lution, the noncross-linked peptide was analyzed by size exclu-
sion chromatography. A relatively short column was used to
diminish dilution effects. When injected at a concentration of
85 or 8.5 mM, the peptide eluted as a single sharp symmetric
peak; in the former case, it eluted between the positions of
carbonic anhydrase and myoglobin, and in the latter case,
between those of cytochrome c and acetone (Fig. 3B). These
results indicate that at the lower concentration, the peptide
dissociates into monomeric chains of random-coil conformation,
whereas at the higher concentration, they elute as an oligomer
of extended structure with a hydrodynamic radius greater than
that of a protein of globular shape as myoglobin (Mr 5 17,200).
When a similar peptide corresponding to the 36 C-terminal
residues of matrilin-1 (11) was chromatographed under the
same conditions, it eluted in the position of carbonic anhydrase.
The combined data from cross-linking and gel chromatogra-
phy are most consistent with the assumption that MTR2-C38
forms a rod-shaped homotrimer in solution. The heterogeneity
observed upon cross-linking is probably due to the reaction
mechanisms of BS3 and disuccinimidyl glutarate. Their princi-
pal targets are primary amines, such as the amino group at the
N terminus of the peptide chains and the e-amino group of
lysine residues (30). The human matrilin-1 domain has four
lysines. According to their optimized positioning into heptads,
one is located near the center of the coiled coil (heptad positions
g). Within MTR2-C38, the two lysines are probably more ex-
posed to the surface of the coiled coil in heptad positions b and
c (Fig. 1). Thus the probability for an intermolecular cross-link
between them is substantially lower, and besides one cross-link
between the N-terminal amino groups covalently stabilizing a
dimer, at least one further cross link is necessary to observe a
trimer on SDS gels. The population of peptides running in the
dimer position (Fig. 3A) might include intermolecular cross
links between both the N termini and one or two of the lysines,
which excludes their native third chain partner from partici-
pating in a covalent structure and lets this chain run in the
monomeric position. A similar heterogeneity of bands on SDS
gels upon cross-linking with BS3, where the majority of the
material runs in the monomer position, has also been observed
for a rat mannose-binding protein fragment, the crystal struc-
ture of which shows a three-stranded a-helical coiled coil con-
taining four lysine residues (31).
FIG. 2. CD spectra of peptide MTR2-C38. Spectra were recorded
at 0 °C in the absence (solid line ) and presence (dashed line) of 50%
trifluoroethanol (peptide concentration: 20 mM in 150 mM NaF, 20 mM
KH2PO4/NaOH, pH 7.2). The inset shows the ellipticity ratios [Q]222/
[Q]208 determined at different peptide concentrations in the same buffer
without trifluoroethanol.
FIG. 3. Oligomerization state of peptide MTR2-C38. A, MTR2-
C38 (100 mM) was incubated with various concentrations (top row, in
mM) of the cross-linkers disuccinimidyl glutarate (DSG) (left) and BS3
(right) for 1 h and analyzed by SDS Tris-Tricine gel electrophoresis. The
position of molecular weight marker proteins are shown on the left, and
the assignment of monomer (M), dimer (D) and trimer (T) positions are
on the right. B, upon gel filtration on a Superdex 75 column, the
MTR2-C38 elution position corresponds to a viscosity radius of 2.0 nm
(M) when injected at high concentration (c 5 85 mM), whereas at low
concentration, it elutes corresponding to a radius of 1.5 nm (E, c 5 8.5
mM). The calibration standards (Ref. 19) are bovine serum albumin (1),
ovalbumin (2), trypsin inhibitor (3), carbonic anhydrase (4), myoglobin
(5), and cytochrome c (6). The reduced retention volume Kav 5 (Ve
2V0)/(Vt 2 V0) was determined assuming that the elution positions Ve
of laminin and acetone indicate the void volume V0 and total volume Vt
of the column, respectively.
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Thermal Stability of Peptide MTR2-C38—To measure the
thermal stability and evaluate the nature of the folding/unfold-
ing transition of MTR2-C38, the CD signal at 222 nm was
monitored at peptide concentrations ranging from 5 to 85 mM
upon raising the temperature. The melting curves showed a
sigmoidal shape indicating a cooperative unfolding from a
coiled-coil to random-coil conformation. The first derivatives
dU/dt exhibit a single minimum that is compatible with the
assumption of a single transition (data not shown). Transition
curves were converted to the fraction of folded protein (Fig. 4A).
Assuming a first order transition reflecting the unfolding of
three peptide chains in a coiled-coil conformation into single
random-coil chains, the data were analyzed for the melting
temperature and transition enthalpies by nonlinear least-
squares fitting to Equation 2. As expected for the unfolding of
noncovalently associated peptide chains, the melting tempera-
ture varied with concentration ranging from 38.2 °C deter-
mined at 5 mM to 50.9 °C at 85 mM (Fig. 4B). These tempera-
tures are about 35 °C lower than those of a corresponding
peptide of matrilin-1 at similar concentrations (11). From the
slope of 1/Tm versus ln (0.75 c0
2), the enthalpy change results to
2375 kJ/mol, which is consistent with DH0 values resulting
from fitting the single transition curves but significantly lower
in its amount than the 2508 kJ/mol reported for the matrilin-1
peptide (11). Assuming that the entire peptide chain partici-
pates in the coiled-coil conformation, a mean value of 23.3
kJ/mol/residue results that is within the range of 21.8 to 24.6
kJ/mol/residue measured calorimetrically for a large number of
coiled-coil proteins (32).
DISCUSSION
The a-helical coiled coil is a ubiquitous structural domain
found in many intra- and extracellular proteins within which it
specifically serves as a region for polypeptide chain recognition
and oligomerization (for recent reviews, see Refs. 24 and 33).
Despite its relatively simple heptad sequence motif where hy-
drophobic residues are predominently located in a 3-4-3-4 spac-
ing, it is difficult to predict the correct oligomerization state.
Thus the multidimensional scoring approach for identifying
and distinguishing between dimeric and trimeric coiled coils
implemented in the MultiCoil program (20) favors a dimer
assembly for matrilin-2 (Fig. 1) as well as for matrilin-1 (data
not shown). For matrilin-1, different approaches have conclu-
sively shown that it forms a homotrimeric a-helical coiled coil
(4, 10, 11), and the data presented here make this the most
likely assembly state also for matrilin-2. Some important rules
for predicting the association state of coiled coils were derived
from the systematic exchange of hydrophobic residues in hep-
tad positions a and d within the yeast transcription factor
GCN4. The geometry of the Ca-Cb bond of the core residues is
parallel to the Ca-Cb vector of the opposing hole in heptad
position a and perpendicular in position d for the dimeric
variant, whereas the trimeric variant shows acute geometry of
these residues, and in the tetrameric one, a is perpendicular,
and d is parallel (34). Although the periodicity of hydrophobic
residues is less regular within the matrilin C-terminal do-
mains, the predominance of leucine residues assigned to posi-
tions a and d according to these rules is consistent with a
trimeric state. It has been shown, however, that a single resi-
due, Arg-487 of the human matrilin-1 sequence, which is prob-
ably involved in an interchain ionic interaction with Glu-492, is
crucial for trimer formation; when replaced by Gln within a
peptide resembling the C-terminal domain, tetramer formation
was observed at physiological pH and ionic strength (26). In-
terestingly, the positively charged character of Arg-487 is con-
served within all matrilin sequences. The corresponding resi-
dues of matrilin-2 studied here are Arg-945/Glu-950 (Fig. 1,
thick bracket) and are identical both in the mouse and human
sequence (12). The matrilin-3 sequences contain a lysine in-
stead of arginine in this position (13, 14).
When compared with the peptide corresponding to the C
terminus of matrilin-1, MTR2-C38 is considerably less stable
with Tm values about 35 °C lower, and the enthalpy change
differs by ;130 kJ/mol (11). This is most probably due to the
weakening in the stabilizing interactions between hydrophobic
core residues. Matrilin-2 residues Ala-928, Met-942, and Met-
946, which are assigned to heptad positions a and d (Fig. 1), are
considerably less hydrophobic than the corresponding amino
acids (Val-470, Val-484, Leu-488) of matrilin-1. Based on model
peptides, it was found that depending on its position, an Ala-
Ala interaction can decrease the stability by DDGu ; 13 kJ/mol
when compared with a Leu-Leu interaction (29). Although me-
thionine residues are relatively rare in coiled-coil domains,
their preference to occupy heptad positions a or d is less pro-
nounced than observed for other hydrophobic amino acids (21,
35), which might indicate that their contribution to stability is
weak.
The most conserved residue pair within the currently known
C-terminal sequences of matrilins is Phe-Gln-925 of matrilin-2
(exceptions: Phe-Glu in mouse matrilin-1; Leu-Gln in chicken
matrilin-3). Interestingly, Gln is specifically found near the N
terminus of many trimeric in contrast to dimeric coiled coils
(36). Indeed, Gln residues in the heptad position a are thought
to specify a trimer assembly (37). Heteronuclear NMR assign-
ments for the chicken matrilin-1 C-terminal domain containing
the two cysteine residues preceding the coiled-coil region indi-
FIG. 4. Thermal denaturation of peptide MTR2-C38. A, the ther-
mal transition was recorded by following the CD signal change at 222
nm and normalized to the fraction of folded peptide (left ordinate,
straight line; (c) 5 42 mM). The dotted line represents the same curve
plotted as ln K(T) (right ordinate) derived from the fraction folded,
assuming a two-state transition from a three-stranded a-helical coiled
coil to random-coil monomers. DH0 and Tm values were derived from
such curves by least-squares fitting as described under “Experimental
Procedures” (Equation 2). B, from the slope of the straight line of the
reciprocal transition temperature versus ln (0.75 c2) results DH0 5
2375 kJ/mol (Equation 1). The inset shows the same values plotted as
Tm(c).
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cate that they form symmetric disulfide bonds in which the first
cysteine of one chain is linked to the second cysteine of a
neighboring chain, contributing a stabilizing energy of DDGu ;
4 kJ/mol. They are incompatible with a coiled-coil conforma-
tion, but this starts at the following residue and lasts up to near
the C terminus (23). In the reduced form, however, the N
termini of this domain are less ordered (23). These results
suggest for MTR2-C38 that the ;10 N-terminal residues are
not well ordered and thus account for the less than fully a-hel-
ical structure as determined by CD spectroscopy (Fig. 2).
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